NasdaqGS:TXGLife Sciences
10x Genomics Joins CRISPR Atlas Effort As Long Term Demand Test
10x Genomics (NasdaqGS:TXG) joined PerturbAI, NVIDIA, and the Allen Institute to help build and analyze what is being described as the world's largest in vivo CRISPR atlas.
The project uses 10x Genomics' technology to connect genetic perturbations with cellular responses at scale, supporting causal genomics research.
The new dataset is expected to be used in therapeutic discovery and is drawing attention from researchers and investors.
For investors watching NasdaqGS:TXG, this scientific...